J1577 HCPCS code: Injection, immune globulin (qivigy), 100 mg
J1577 is the HCPCS Level II code for injection, immune globulin (qivigy), 100 mg. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2026-07-01 |
| Last action effective | 2026-07-01 |
Medicare policy articles for this code
- A52509: Intravenous Immune Globulin - Policy Article (CGS Administrators, LLC (DME MAC) Noridian Healthcare Solutions, LLC (DME MAC)) — mentions this code in its coding guidance
- A56786: Billing and Coding: Immune Globulin (Novitas Solutions, Inc. (MAC - Part A, MAC - Part B))
- A57187: Billing and Coding: Immune Globulin Intravenous (IVIg) (Noridian Healthcare Solutions, LLC (MAC - Part A, MAC - Part B))
- A57554: Billing and Coding: Immune Globulins (WPS Insurance Corporation (MAC - Part A, MAC - Part B))
- A57778: Billing and Coding: Immune Globulin (First Coast Service Options, Inc. (MAC - Part A, MAC - Part B))
- A59105: Billing and Coding: Off-Label Use of Intravenous Immune Globulin (IVIG) (Wellpoint Federal (MAC - Part A, MAC - Part B))
Covered diagnoses (1,360 ICD-10-CM codes)
The diagnoses most often listed as covered in the policy articles above:
| ICD-10-CM | Diagnosis | Articles listing it |
|---|---|---|
| D80.0 | Hereditary hypogammaglobulinemia | 6 |
| D80.2 | Selective deficiency of immunoglobulin A [IgA] | 6 |
| D80.3 | Selective deficiency of immunoglobulin G [IgG] subclasses | 6 |
| D80.4 | Selective deficiency of immunoglobulin M [IgM] | 6 |
| D80.5 | Immunodeficiency with increased immunoglobulin M [IgM] | 6 |
| D80.6 | Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinemia | 6 |
| D80.7 | Transient hypogammaglobulinemia of infancy | 6 |
| D81.0 | Severe combined immunodeficiency [SCID] with reticular dysgenesis | 6 |
| D81.1 | Severe combined immunodeficiency [SCID] with low T- and B-cell numbers | 6 |
| D81.2 | Severe combined immunodeficiency [SCID] with low or normal B-cell numbers | 6 |
Showing 10 of 1,360. The full list, non-covered diagnoses and CSV export are in Caduvo.
What changed for J1577
- July 2026: Code appears in this HCPCS release
- 2026-07-01: J1577 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J1577?
J1577 is the HCPCS Level II code for injection, immune globulin (qivigy), 100 mg. Short descriptor: "Inj, qivigy, 100mg".
Does Medicare cover J1577?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
Which diagnoses support coverage for J1577?
Medicare policy articles that cite J1577 list 1,360 covered ICD-10-CM diagnosis codes across 6 articles. The most cited include D80.0 (Hereditary hypogammaglobulinemia), D80.2 (Selective deficiency of immunoglobulin A [IgA]), D80.3 (Selective deficiency of immunoglobulin G [IgG] subclasses). A listed diagnosis is necessary but not sufficient; the policy's other criteria still apply.
Related J15 codes
- J1551 — Injection, immune globulin (cutaquig), 100 mg
- J1552 — Injection, immune globulin (alyglo), 500 mg
- J1553 — Injection, immune globulin (yimmugo), 100 mg
- J1554 — Injection, immune globulin (asceniv), 500 mg
- J1555 — Injection, immune globulin (cuvitru), 100 mg
- J1556 — Injection, immune globulin (bivigam), 500 mg
- J1557 — Injection, immune globulin, (gammaplex), intravenous, non-lyophilized (e.g., liquid), 500 mg
- J1558 — Injection, immune globulin (xembify), 100 mg
- J1559 — Injection, immune globulin (hizentra), 100 mg
- J1560 — Injection, gamma globulin, intramuscular, over 10 cc
- J1561 — Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg
- J1562 — Injection, immune globulin (vivaglobin), 100 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J1577
- Watch J1577 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J1577
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.